SCHEDULE: Vanguard Boosts Stake in Avanos Medical to 7.38%
Beneficial Ownership Report (Amendment)
The Vanguard Group has disclosed an increased beneficial ownership of 7.38% in Avanos Medical Inc., holding over 3.4 million shares.
Summary
- The Vanguard Group reported beneficial ownership of 3,425,214 shares of Avanos Medical Inc. common stock.
- This represents 7.38% of the class of securities.
- Vanguard holds sole dispositive power over 2,979,548 shares and shared dispositive power over 445,666 shares.
- Vanguard holds shared voting power over 371,596 shares and no sole voting power.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Avanos Medical Inc.
Sentiment
Score: 7
Explanation: The filing indicates a significant and ongoing institutional investment by The Vanguard Group, suggesting a degree of confidence in Avanos Medical Inc. from a major asset manager. While a 13G is a factual disclosure, a large institutional stake is generally viewed positively.
Positives
- A significant stake by a major institutional investor like The Vanguard Group can signal confidence in the company's long-term prospects.
- The holding of 7.38% indicates substantial institutional interest in Avanos Medical Inc.
Negatives
- This filing does not contain information that would be considered negative for Avanos Medical Inc.
Risks
- This filing does not contain information regarding specific risks for Avanos Medical Inc.
Future Outlook
This filing does not provide any forward-looking statements or guidance from Avanos Medical Inc. or The Vanguard Group regarding the issuer's future performance.
Industry Context
The disclosure of a significant stake by a major asset manager like Vanguard is a routine part of institutional investment. It reflects Vanguard's strategy of passive or active investment across various sectors, including healthcare, and indicates their current portfolio allocation to Avanos Medical Inc. within the broader medical technology industry.
Comparison to Industry Standards
- The Vanguard Group is one of the largest investment management companies globally, known for its broad market index funds and ETFs. Its significant stake in Avanos Medical Inc. is consistent with its strategy of holding diversified portfolios across various industries.
- A 7.38% stake is a substantial position for an institutional investor, placing Vanguard among the top shareholders, which is common for large asset managers in publicly traded companies.
Stakeholder Impact
- Shareholders: The presence of a large institutional investor like Vanguard can provide stability and potentially influence corporate governance through voting power, even if passive.
- Company Management: Awareness of a significant institutional holder may influence strategic decisions, though Vanguard's stated purpose is not to influence control.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement (end of reporting period) |
| 10/30/2025 | Signature date of the filing |
Keywords
Avanos Medical Inc, Vanguard Group, Beneficial Ownership, Institutional Investor, Common Stock, Medical Devices, Healthcare, SEC Filing, Schedule 13G
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.